This compound is primarily utilized in the field of medicinal chemistry due to its structural similarity to biologically active molecules. It serves as a key intermediate in the synthesis of pharmaceutical agents, particularly those targeting neurological disorders. Its dibenzoazepine moiety is known for interacting with neurotransmitter systems, making it valuable in the development of drugs for conditions like depression, anxiety, and epilepsy. Additionally, the isoindoline-1,3-dione group enhances its potential as a precursor for creating compounds with anti-inflammatory or anticonvulsant properties. Researchers also explore its use in designing novel therapeutic agents for neurodegenerative diseases, leveraging its ability to modulate specific receptors in the brain.